Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TXNDC11 Antisense RNA 1 (TXNDC11-AS1) is a human long non-coding RNA (lncRNA) gene located antisense to the TXNDC11 protein-coding gene. Identified in genome annotation sources and referenced in transcriptomic studies, TXNDC11-AS1 is part of the lncRNA class and is presumed to regulate TXNDC11 expression at the RNA level, possibly by mechanisms typical for antisense RNAs such as interfering with mRNA transport or stabilizing mRNA. However, no specific biological functions, disease roles, or drug interactions have been validated for TXNDC11-AS1 as of 2024. All disease associations in the literature currently refer to the protein-coding gene TXNDC11, not its antisense RNA.
Not applicable, as there are no drugs targeting TXNDC11-AS1 directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TXNDC11 Antisense RNA 1 (TXNDC11-AS1).